The Role of MiRNA in Retinal Ganglion Cell Health and Disease

Overview

Journal Neural Regen Res

Date 2021 Aug 12

PMID 34380881

Citations 11

Authors

Ben Mead

Stanislav Tomarev

Affiliations

Soon will be listed here.

Abstract

miRNA are short non-coding RNA responsible for the knockdown of proteins through their targeting and silencing of complimentary mRNA sequences. The miRNA landscape of a cell thus affects the levels of its proteins and has significant consequences to its health. Deviations in this miRNA landscape have been implicated in a variety of neurodegenerative diseases and have also garnered interest as targets for treatment. Retinal ganglion cells are the sole projection neuron of the retina with their axons making up the optic nerve. They are a focus of study not only for their importance in vision and the myriad of blinding diseases characterized by their dysfunction and loss, but also as a model of other central nervous system diseases such as spinal cord injury and traumatic brain injury. This review summarizes current knowledge on the role of miRNA in retinal ganglion cell function, highlighting how perturbations can result in disease, and how modulating their abundance may provide a novel avenue of therapeutic research.

Citing Articles

Glaucomatous retinal ganglion cells: death and protection.

Cui N, Jia J, He Y Int J Ophthalmol. 2025; 18(1):160-167.

PMID: 39829615 PMC: 11672089. DOI: 10.18240/ijo.2025.01.20.

miRNA changes associated with differentiation of human embryonic stem cells into human retinal ganglion cells.

Esmaeili M, Smith D, Mead B Sci Rep. 2024; 14(1):31895.

PMID: 39738601 PMC: 11685716. DOI: 10.1038/s41598-024-83381-9.

A universal orthogonal imaging platform for living-cell RNA detection using fluorogenic RNA aptamers.

Yin P, Ge M, Xie S, Zhang L, Kuang S, Nie Z Chem Sci. 2023; 14(48):14131-14139.

PMID: 38098702 PMC: 10717586. DOI: 10.1039/d3sc04957d.

Anti-vascular endothelial growth factor drugs combined with laser photocoagulation maintain retinal ganglion cell integrity in patients with diabetic macular edema: study protocol for a prospective, non-randomized, controlled clinical trial.

Li X, Li C, Huang H, Bai D, Wang J, Chen A Neural Regen Res. 2023; 19(4):923-928.

PMID: 37843230 PMC: 10664114. DOI: 10.4103/1673-5374.382104.

The SMAD2/miR-4256/HDAC5/p16 signaling axis contributes to gastric cancer progression.

Wang M, Zhao H, Chen W, Bie C, Yang J, Cai W Oncol Res. 2023; 31(4):515-541.

PMID: 37415735 PMC: 10319587. DOI: 10.32604/or.2023.029101.

References

Hackler Jr L, Wan J, Swaroop A, Qian J, Zack D . MicroRNA profile of the developing mouse retina. Invest Ophthalmol Vis Sci. 2009; 51(4):1823-31. PMC: 2868396. DOI: 10.1167/iovs.09-4657. View

Sundermeier T, Palczewski K . The impact of microRNA gene regulation on the survival and function of mature cell types in the eye. FASEB J. 2015; 30(1):23-33. PMC: 4684546. DOI: 10.1096/fj.15-279745. View

Fu J, Peng L, Tao T, Chen Y, Li Z, Li J . Regulatory roles of the miR-200 family in neurodegenerative diseases. Biomed Pharmacother. 2019; 119:109409. DOI: 10.1016/j.biopha.2019.109409. View

Klatt C, Theis V, Hahn S, Theiss C, Matschke V . Deregulated Correlates with Tissue-Specific Activation of Intrinsic Apoptosis in An Animal Model of Amyotrophic Lateral Sclerosis. Cells. 2019; 8(9). PMC: 6770833. DOI: 10.3390/cells8091077. View

Berry M, Ahmed Z, Logan A . Return of function after CNS axon regeneration: Lessons from injury-responsive intrinsically photosensitive and alpha retinal ganglion cells. Prog Retin Eye Res. 2018; 71:57-67. DOI: 10.1016/j.preteyeres.2018.11.006. View

Jayaram H, Cepurna W, Johnson E, Morrison J . MicroRNA Expression in the Glaucomatous Retina. Invest Ophthalmol Vis Sci. 2016; 56(13):7971-82. PMC: 4684194. DOI: 10.1167/iovs.15-18088. View

Fujita K, Nishiguchi K, Shiga Y, Nakazawa T . Spatially and Temporally Regulated Gene Therapy Using Promoter in Retinal Ganglion Cell Injury. Mol Ther Methods Clin Dev. 2017; 5:130-141. PMC: 5415330. DOI: 10.1016/j.omtm.2017.04.003. View

Johnson R, Buckley N . Gene dysregulation in Huntington's disease: REST, microRNAs and beyond. Neuromolecular Med. 2009; 11(3):183-99. DOI: 10.1007/s12017-009-8063-4. View

Wang Y, Wang X, Jiang Y, Liu R, Cao D, Pan J . Identification of key miRNAs and genes for mouse retinal development using a linear model. Mol Med Rep. 2020; 22(1):494-506. PMC: 7248464. DOI: 10.3892/mmr.2020.11082. View

10.

Williams P, Benowitz L, Goldberg J, He Z . Axon Regeneration in the Mammalian Optic Nerve. Annu Rev Vis Sci. 2020; 6:195-213. DOI: 10.1146/annurev-vision-022720-094953. View

11.

Park K, Liu K, Hu Y, Kanter J, He Z . PTEN/mTOR and axon regeneration. Exp Neurol. 2010; 223(1):45-50. DOI: 10.1016/j.expneurol.2009.12.032. View

12.

Aggio-Bruce R, Chu-Tan J, Wooff Y, Cioanca A, Schumann U, Natoli R . Inhibition of microRNA-155 Protects Retinal Function Through Attenuation of Inflammation in Retinal Degeneration. Mol Neurobiol. 2020; 58(2):835-854. PMC: 7843561. DOI: 10.1007/s12035-020-02158-z. View

13.

Zhou H, Su J, Hu X, Zhou C, Li H, Chen Z . Glia-to-Neuron Conversion by CRISPR-CasRx Alleviates Symptoms of Neurological Disease in Mice. Cell. 2020; 181(3):590-603.e16. DOI: 10.1016/j.cell.2020.03.024. View

14.

Rodriguez A, Perez de Sevilla Muller L, Brecha N . The RNA binding protein RBPMS is a selective marker of ganglion cells in the mammalian retina. J Comp Neurol. 2013; 522(6):1411-43. PMC: 3959221. DOI: 10.1002/cne.23521. View

15.

Libby R, Li Y, Savinova O, Barter J, Smith R, Nickells R . Susceptibility to neurodegeneration in a glaucoma is modified by Bax gene dosage. PLoS Genet. 2005; 1(1):17-26. PMC: 1183523. DOI: 10.1371/journal.pgen.0010004. View

16.

Mead B, Amaral J, Tomarev S . Mesenchymal Stem Cell-Derived Small Extracellular Vesicles Promote Neuroprotection in Rodent Models of Glaucoma. Invest Ophthalmol Vis Sci. 2018; 59(2):702-714. PMC: 5795911. DOI: 10.1167/iovs.17-22855. View

17.

Xia X, Wang Y, Zheng J . The microRNA-17 ~ 92 Family as a Key Regulator of Neurogenesis and Potential Regenerative Therapeutics of Neurological Disorders. Stem Cell Rev Rep. 2020; 18(2):401-411. PMC: 8930872. DOI: 10.1007/s12015-020-10050-5. View

18.

Xia X, Wang Y, Huang Y, Zhang H, Lu H, Zheng J . Exosomal miRNAs in central nervous system diseases: biomarkers, pathological mediators, protective factors and therapeutic agents. Prog Neurobiol. 2019; 183:101694. PMC: 7323939. DOI: 10.1016/j.pneurobio.2019.101694. View

19.

He Y, Li H, Li X, Zhou Y, Xia X, Song W . MiR-124 Promotes the Growth of Retinal Ganglion Cells Derived from Müller Cells. Cell Physiol Biochem. 2018; 45(3):973-983. DOI: 10.1159/000487292. View

20.

Kole C, Brommer B, Nakaya N, Sengupta M, Bonet-Ponce L, Zhao T . Activating Transcription Factor 3 (ATF3) Protects Retinal Ganglion Cells and Promotes Functional Preservation After Optic Nerve Crush. Invest Ophthalmol Vis Sci. 2020; 61(2):31. PMC: 7326601. DOI: 10.1167/iovs.61.2.31. View